LVM Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-49,306
| Closed | -$3.76M | – | 148 |
|
|
2023
Q1 | $3.76M | Sell |
49,306
-2,350
| -5% | -$179K | 0.52% | 45 |
|
|
2022
Q4 | $4.29M | Sell |
51,656
-7,132
| -12% | -$592K | 0.62% | 45 |
|
|
2022
Q3 | $4.66M | Sell |
58,788
-6,290
| -10% | -$499K | 0.71% | 41 |
|
|
2022
Q2 | $4.83M | Sell |
65,078
-12,000
| -16% | -$891K | 0.7% | 41 |
|
|
2022
Q1 | $6.93M | Buy |
77,078
+5,447
| +8% | +$490K | 0.92% | 37 |
|
|
2021
Q4 | $8.02M | Buy |
71,631
+1,271
| +2% | +$142K | 1.07% | 34 |
|
|
2021
Q3 | $8.85M | Buy |
70,360
+1,921
| +3% | +$241K | 1.33% | 28 |
|
|
2021
Q2 | $9.27M | Buy |
68,439
+2,325
| +4% | +$315K | 1.41% | 27 |
|
|
2021
Q1 | $8.97M | Sell |
66,114
-752
| -1% | -$102K | 1.45% | 27 |
|
|
2020
Q4 | $9.41M | Sell |
66,866
-710
| -1% | -$100K | 1.59% | 25 |
|
|
2020
Q3 | $7.53M | Buy |
67,576
+6,180
| +10% | +$689K | 1.46% | 26 |
|
|
2020
Q2 | $6.87M | Buy |
+61,396
| New | +$6.87M | 1.41% | 27 |
|